US equities
|
NVDA
$239.60
▲+2.42%
SPCX
$169.72
▲+6.77%
MU
$1,061.83
▼-1.22%
TSLA
$380.36
▲+2.64%
SNDK
$1,696.04
▼-1.39%
MSFT
$528.48
▲+2.12%
INTC
$116.39
▼-2.46%
META
$744.03
▲+2.19%
NVDA
$239.60
▲+2.42%
SPCX
$169.72
▲+6.77%
MU
$1,061.83
▼-1.22%
TSLA
$380.36
▲+2.64%
SNDK
$1,696.04
▼-1.39%
MSFT
$528.48
▲+2.12%
INTC
$116.39
▼-2.46%
META
$744.03
▲+2.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Relmada Therapeutics, Inc. - Common Stock
(NQ:
RLMD
)
3.485
-0.115 (-3.19%)
Delayed Quote
Updated: 3:22 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Loading chart...